These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 29486297

  • 1. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.
    Si Y, Cui X, Crossman DK, Hao J, Kazamel M, Kwon Y, King PH.
    Neurobiol Dis; 2018 Jun; 114():85-94. PubMed ID: 29486297
    [Abstract] [Full Text] [Related]

  • 2. The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis.
    Si Y, Kazamel M, Kwon Y, Lee I, Anderson T, Zhou S, Bamman M, Wiggins D, Kwan T, King PH.
    J Steroid Biochem Mol Biol; 2020 Jun; 200():105650. PubMed ID: 32142934
    [Abstract] [Full Text] [Related]

  • 3. Transforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression.
    Si Y, Kim S, Cui X, Zheng L, Oh SJ, Anderson T, AlSharabati M, Kazamel M, Volpicelli-Daley L, Bamman MM, Yu S, King PH.
    PLoS One; 2015 Jun; 10(9):e0138425. PubMed ID: 26375954
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.
    Toivonen JM, Manzano R, Oliván S, Zaragoza P, García-Redondo A, Osta R.
    PLoS One; 2014 Jun; 9(2):e89065. PubMed ID: 24586506
    [Abstract] [Full Text] [Related]

  • 5. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D, Romberg CF, Dobrowolny G, Martini M, Voss AA, Musarò A, Bannister RA.
    Skelet Muscle; 2016 Jun; 6():24. PubMed ID: 27340545
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.
    Marcuzzo S, Bonanno S, Kapetis D, Barzago C, Cavalcante P, D'Alessandro S, Mantegazza R, Bernasconi P.
    Mol Brain; 2015 Jan 28; 8():5. PubMed ID: 25626686
    [Abstract] [Full Text] [Related]

  • 7. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.
    Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, Zhou J.
    PLoS One; 2013 Jan 28; 8(12):e82112. PubMed ID: 24324755
    [Abstract] [Full Text] [Related]

  • 8. Assessment of metal concentrations in the SOD1G93A mouse model of amyotrophic lateral sclerosis and its potential role in muscular denervation, with particular focus on muscle tissue.
    Enge TG, Ecroyd H, Jolley DF, Yerbury JJ, Kalmar B, Dosseto A.
    Mol Cell Neurosci; 2018 Apr 28; 88():319-329. PubMed ID: 29524628
    [Abstract] [Full Text] [Related]

  • 9. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y, Shimazawa M, Tanaka H, Ono Y, Noda Y, Ohuchi K, Tsuruma K, Katsuno M, Sobue G, Hara H.
    J Neurosci Res; 2015 Oct 28; 93(10):1552-66. PubMed ID: 26140698
    [Abstract] [Full Text] [Related]

  • 10. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M.
    Exp Neurol; 2016 Mar 28; 277():275-282. PubMed ID: 26775178
    [Abstract] [Full Text] [Related]

  • 11. Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis.
    Kwan T, Kazamel M, Thoenes K, Si Y, Jiang N, King PH.
    Sci Rep; 2020 Oct 07; 10(1):16679. PubMed ID: 33028902
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 07; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.
    Lu CH, Petzold A, Kalmar B, Dick J, Malaspina A, Greensmith L.
    PLoS One; 2012 Apr 07; 7(7):e40998. PubMed ID: 22815892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G, Simonet T, Bauché S, Mandjee N, Malfatti E, Girard E, Tanguy ML, Behin A, Khiami F, Sariali E, Hell-Remy C, Salachas F, Pradat PF, Fournier E, Lacomblez L, Koenig J, Romero NB, Fontaine B, Meininger V, Schaeffer L, Hantaï D.
    Brain; 2013 Aug 07; 136(Pt 8):2359-68. PubMed ID: 23824486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.